Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse

BACKGROUND: The detection of cytokeratin-19 (CK-19) mRNA-positive circulating tumor cells (CTC) before and/or after adjuvant chemotherapy in patients with operable breast cancer is associated with poor clinical outcome. Reliable prognostic markers for late disease relapse are not available. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Saloustros, Emmanouil, Perraki, Maria, Apostolaki, Stella, Kallergi, Galatea, Xyrafas, Alexandros, Kalbakis, Kostas, Agelaki, Sophia, Kalykaki, Antonia, Georgoulias, Vassilis, Mavroudis, Dimitris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218949/
https://www.ncbi.nlm.nih.gov/pubmed/21663668
http://dx.doi.org/10.1186/bcr2897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218949/
https://www.ncbi.nlm.nih.gov/pubmed/21663668
http://dx.doi.org/10.1186/bcr2897

Ejemplares similares